調查批次:CHT2017-03 | 檢體寄出日期:2017-06-26 | 報告回收截止日期:2017-07-03 | 回收份數:22 |
T3 檢驗院際品管調查結果: | ||
2.歷次品管檢體 T3 檢驗值之實驗室間 CV 分佈圖 | ||
4.至本次各單位 z score 分佈圖 | 5.至本次各單位 D% 分佈圖 | 6.至本次各單位 SDI 分佈圖 |
檢驗單位 <代碼> |
確診醫院 <代碼> |
回報 天數 |
檢體 S1 |
檢體 S2 |
||||||||||||
( ng/dL ) |
D |
D% |
z |
SDI |
Da% |
( ng/dL ) |
D |
D% |
z |
SDI |
Da% |
|||||
RH01b | RH01 | 1 |
2 |
5 |
262 |
2 |
0.8 |
0.1 |
1.1 |
3 |
215 |
0 |
0.0 |
0.0 |
1.8 |
0 |
RH07b | RH07 | 4 |
2 |
3 |
228 |
-32 |
-12.3 |
-1.5 |
-0.8 |
-51 |
177 |
-38 |
-17.7 |
-2.2 |
-0.6 |
-74 |
RH14 | RH14 | 4 |
2 |
3 |
259 |
-1 |
-0.4 |
-0.0 |
0.9 |
-2 |
182 |
-33 |
-15.3 |
-1.9 |
-0.3 |
-64 |
RH15 | RH15 | 7 |
2 |
5 |
252 |
-8 |
-3.1 |
-0.4 |
0.5 |
-13 |
200 |
-15 |
-7.0 |
-0.9 |
0.9 |
-29 |
CL009 | CL009 | 4 |
2 |
5 |
230 |
-30 |
-11.5 |
-1.4 |
-0.6 |
-48 |
186 |
-29 |
-13.5 |
-1.7 |
0.0 |
-56 |
CL010 | CL010 | 7 |
2 |
5 |
242 |
-18 |
-6.9 |
-0.9 |
0.0 |
-29 |
195 |
-20 |
-9.3 |
-1.2 |
0.6 |
-39 |
CL012 | CL012 | 8 |
2 |
3 |
179 |
-81 |
-31.2 |
-3.9 |
-3.4 |
-130 |
148 |
-67 |
-31.2 |
-3.9 |
-2.4 |
-130 |
CL014a | CL014 | 4 |
2 |
3 |
235 |
-25 |
-9.6 |
-1.2 |
-0.4 |
-40 |
177 |
-38 |
-17.7 |
-2.2 |
-0.6 |
-74 |
CL015 | CL015 | 7 |
2 |
5 |
256 |
-4 |
-1.5 |
-0.2 |
0.8 |
-6 |
184 |
-31 |
-14.4 |
-1.8 |
-0.1 |
-60 |
Median of RIA Group |
242 |
184 |
||||||||||||||
Range of RIA Group |
179 - 262 |
148 - 215 |
||||||||||||||
Robust mean of RIA Group |
242 ( n = 9 ) |
186 ( n = 9 ) |
||||||||||||||
Robust SD of RIA Group |
18.6 |
16.0 |
||||||||||||||
CV of RIA Group |
7.7% |
8.6% |
||||||||||||||
檢驗單位 <代碼> |
確診醫院 <代碼> |
回報 天數 |
檢體 S1 |
檢體 S2 |
||||||||||||
( ng/dL ) |
D |
D% |
z |
SDI |
Da% |
( ng/dL ) |
D |
D% |
z |
SDI |
Da% |
|||||
RH01a | RH01 | 3 |
4 |
9 |
262 |
2 |
0.8 |
0.1 |
-0.3 |
3 |
207 |
-8 |
-3.7 |
-0.5 |
-0.4 |
-16 |
RH02c | RH02 | 3 |
4 |
1 |
286 |
26 |
10.0 |
1.3 |
0.8 |
42 |
232 |
17 |
7.9 |
1.0 |
1.0 |
33 |
RH06 | RH06 | 7 |
4 |
9 |
256 |
-4 |
-1.5 |
-0.2 |
-0.5 |
-6 |
209 |
-6 |
-2.8 |
-0.3 |
-0.3 |
-12 |
RH07a | RH07 | 7 |
4 |
2 |
253 |
-7 |
-2.7 |
-0.3 |
-0.7 |
-11 |
198 |
-17 |
-7.9 |
-1.0 |
-1.0 |
-33 |
RH12 | RH12 | 4 |
4 |
2 |
240 |
-20 |
-7.7 |
-1.0 |
-1.2 |
-32 |
197 |
-18 |
-8.4 |
-1.0 |
-1.0 |
-35 |
RH15b | RH15b | 4 |
4 |
13 |
288 |
28 |
10.8 |
1.3 |
0.9 |
45 |
224 |
9 |
4.2 |
0.5 |
0.5 |
17 |
RH19 | RH19 | 7 |
4 |
2 |
254 |
-6 |
-2.3 |
-0.3 |
-0.6 |
-10 |
203 |
-12 |
-5.6 |
-0.7 |
-0.7 |
-23 |
RH20 | RH20 | 7 |
4 |
7 |
309 |
49 |
18.8 |
2.4 |
1.8 |
79 |
240 |
25 |
11.6 |
1.5 |
1.4 |
48 |
CL005 | CL005 | 4 |
4 |
9 |
261 |
1 |
0.4 |
0.0 |
-0.3 |
2 |
200 |
-15 |
-7.0 |
-0.9 |
-0.8 |
-29 |
CL006a | CL006 | 7 |
4 |
1 |
272 |
12 |
4.6 |
0.6 |
0.2 |
19 |
223 |
8 |
3.7 |
0.5 |
0.4 |
16 |
CL008 | CL008 | 7 |
4 |
2 |
259 |
-1 |
-0.4 |
-0.0 |
-0.4 |
-2 |
219 |
4 |
1.9 |
0.2 |
0.2 |
8 |
CL011 | CL011 | 1 |
4 |
13 |
307 |
47 |
18.1 |
2.3 |
1.7 |
75 |
240 |
25 |
11.6 |
1.5 |
1.4 |
48 |
CL013b | CL013b | 4 |
4 |
1 |
253 |
-7 |
-2.7 |
-0.3 |
-0.7 |
-11 |
202 |
-13 |
-6.0 |
-0.8 |
-0.7 |
-25 |
Median of CLIA Group |
261 |
209 |
||||||||||||||
Range of CLIA Group |
240 - 309 |
197 - 240 |
||||||||||||||
Robust mean of CLIA Group |
268 ( n = 13 ) |
215 ( n = 13 ) |
||||||||||||||
Robust SD of CLIA Group |
22.9 |
17.8 |
||||||||||||||
CV of CLIA Group |
8.5% |
8.3% |
||||||||||||||
Median of All Labs |
256 |
201 |
||||||||||||||
Range of All Labs |
179 - 309 |
148 - 240 |
||||||||||||||
Robust mean of All Labs |
257 ( n = 22 ) |
203 ( n = 22 ) |
||||||||||||||
Robust SD of All Labs |
22.2 |
22.2 |
||||||||||||||
CV of All Labs |
8.6% |
10.9%
|
||||||||||||||
Certified assigned value ( Xa )( ng/dL ) |
260 |
215 |
||||||||||||||
Expanded uncertainty ( Ua ) |
2.60 |
2.28 |
||||||||||||||
Relative expanded uncertainty |
1.0% |
1.0% |
||||||||||||||
Coverage factor k |
2.6 |
2.6 |
||||||||||||||
Effective degrees of freedom veff |
5 |
5 |
||||||||||||||
SD for proficiency assessment ( σp ) |
20.8 |
17.20 |
||||||||||||||
Adjusted SD for proficiency assessment ( σp ' ) |
- |
- |
||||||||||||||
|
Method Code
|
Laboratory |
|
Radioimmunoassay ( Competitive-type ) |
2 |
RH01b, RH07b, RH14, RH15, CL009, CL010, CL012, CL014a, CL015, |
Chemiluminescent Immunoassay ( Competitive-type ) |
4 |
RH01a, RH02c, RH06, RH07a, RH12, RH15b, RH19, RH20, CL005, CL006a, CL008, CL011, CL013b, |
Reagent Code |
Laboratory |
|
Abbott Architect |
1 |
RH02c, CL006a, CL013b, |
Beckman Coulter Access |
2 |
RH07a, RH12, RH19, CL008, |
Cisbio RIA-gnost |
3 |
RH07b, RH14, CL012, CL014a, |
Immunotech |
5 |
RH01b, RH15, CL009, CL010, CL015, |
Siemens ADVIA Centaur |
7 |
RH20, |
Siemens Immulite 2000 |
9 |
RH01a, RH06, CL005, |
Roche |
13 |
RH15b, CL011, |
若有任何疑問,歡迎來電(函)聯繫或指教
財團法人預防醫學基金會
地 址:10699 臺北信維郵局第 624 信箱 電 話:(02)
2703-6080
e-mail:
傳 真: (02)
2703-6070
updated
: 2017-07-05